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Abstract
Vinyl chloride (VC) is an industrial chemical that is known to be carcinogenic to animals and
humans. VC primarily induces hepatic angiosarcomas following high exposures (≥50 ppm). VC is
also found in Superfund sites at ppb concentrations as a result of microbial metabolism of
trichloroethylene and perchloroethylene. Here, we report a new sensitive LC-MS/MS method to
analyze the major DNA adduct formed by VC, 7-(2-oxoethylguanine) (7-OEG). We used this
method to analyze tissue DNA from both adult and weanling rats exposed to 1100 ppm [13C2]-VC
for 5 days. After neutral thermal hydrolysis, 7-OEG was derivatized with O-t-butyl hydroxylamine
to an oxime adduct, followed by LC-MS/MS analysis. The limit of detection was 1 fmol and the
limit of quantitation was 1.5 fmol on the column. The use of stable isotope VC allowed us to
demonstrate for the first time that endogenous 7-OEG was present in tissue DNA. We
hypothesized that endogenous 7-OEG was formed from lipid peroxidation and demonstrated the
formation of [13C2]-7-OEG from the reaction of calf thymus DNA with [13C18]-ethyl linoleate
(EtLa) under peroxidizing conditions. The concentrations of endogenous 7-OEG in liver, lung,
kidney, spleen, testis and brain DNA from adult and weanling rats typically ranged from 1.0-10.0
adducts per 106 guanine. The exogenous 7-OEG in liver DNA from adult rats exposed to 1100
ppm [13C2]-VC for 5 days was 104.0 ± 23.0 adducts per 106 guanine (n=4), while concentrations
in other tissues ranged from 1.0-39.0 adducts per 106 guanine (n=4). Although endogenous
concentrations of 7-OEG in tissues in weanling rats were similar to those of adult rats, exogenous
[13C2]-7-OEG concentrations were higher in weanlings, averaging 300 adducts per 106 guanine in
liver. Studies on the persistence of [13C2]-7-OEG in adult rats sacrificed 2, 4, and 8 wks post
exposure to [13C2]-VC demonstrated a half-life of 7-OEG of 4 days in both liver and lung.
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Vinyl chloride (VC) is an industrial chemical that is known to be a human and rodent
carcinogen that also is found in over 100 Superfund sites as a result of microbial metabolism
of trichloroethylene (TCE) and perchloroethylene (PCE). VC had been regarded as a
relatively nontoxic industrial chemical until in 1974, the first epidemiology studies of
occupationally exposed workers identified hepatic angiosarcomas, a rare neoplasm in
humans.1-3 VC is still widely used in industry for the preparation of polyvinyl chloride.
While prolonged exposure to high concentrations of VC is known to cause liver
angiosarcoma 4, it remains unclear why carcinogenesis is primarily associated with high
exposures (≥ 50 ppm VC). VC is metabolized by CYP450 2E1 to chloroethylene oxide
(CEO).5, 6 CEO, the ultimate carcinogenic metabolite of VC,7 covalently binds to DNA and
induces four DNA adducts, whereas chloroacetaldehyde, a secondary metabolite reacts
primarily with proteins.8 Although, 7-(2-oxoethyl)guanine (7-OEG) is the major DNA
adduct (~98 %)9-13 that arises from the reaction of CEO with DNA, it has been reported to
be devoid of miscoding properties,14 and it is lost primarily by chemical depurination.
Conversely, exocyclic etheno adducts of VC, N2,3-ethenoguanine (εG), 1,N6-
ethenodeoxyadenosine (εdA) and 3,N4-ethenodeoxycytidine (εdC) display clear
promutagenic activity during DNA synthesis.15-17 Since promutagenic properties of etheno
adducts are known, they have been studied in more detail than 7-OEG in order to further
characterize their molecular dosimetry, promutagenic properties and repair.16-18 Low
concentrations of endogenous etheno adducts have been detected in tissues19-25 and are
believed to result from lipid peroxidation and oxidative stress.26-29 In contrast, 7-OEG
adducts were only known to result from the reaction of CEO (Scheme 1) or the epoxide of
urethane with the nucleophilic N7 position on dG.
Reactive oxygen species (ROS), such as super oxide anion radical (O2−), hydrogen peroxide
(H2O2) and hydroxy radical (.OH), are generated during oxidative stress by biochemical
reactions and cellular functions.30 They are highly reactive with DNA, protein, lipids, and
glycation products and are well known to be cytotoxic.31 While ROS are produced as a
product of normal cellular function (i.e. mitochondrial metabolism), oxidative stress occurs
when an imbalance arises between ROS production and antioxidant capacity, either through
excess ROS production and/or antioxidant depletion. Oxidative stress can induce oxidative
damage in cellular DNA, which if left unrepaired may induce mutations and, thus, play an
important role in multistage carcinogenesis and progression of cancer.32 Excess free radical
formation and oxidative stress are associated with various human diseases including a
variety of cancers, neurodegenerative diseases, aging, and cardiovascular diseases.33-35
Oxidative degeneration of lipids, also known as ‘Lipid Peroxidation’ (LPO), consists of
three major steps: initiation, propagation, and termination. LPO is first initiated by
abstraction of hydrogen from unsaturated fatty acids to generate a fatty acid radical. This is
followed by a reaction with O2 to give a peroxy radical (propagation), which continues a
chain reaction until production is stopped by formation of a non-radical species. Following
oxidation, α,β-unsaturated aldehydes, such as 4-oxo-2-nonenal (ONE), 4-hydroxy-2-nonenal
(HNE), malondialdehyde (MDA), and acrolein, form by the decomposition of
hydroperoxides.36,37 Such aldehydes react with DNA and proteins to induce cell
proliferation and apoptosis.36-38 Some of the LPO induced DNA adducts are εdA, εG and
pyrimido[1,2-a]-purin-10(3H)-one (M1G).39, 40
Previously, VC has been shown to be more carcinogenic in young animals.41-44 Maltoni et
al. showed that 1 day old Sprague-Dawley rats exposed to 6000 or 12000 ppm VC (4 h/day,
5 day/week, 5 weeks) had about a 50 % incidence of angiosarcoma, whereas 13 week old
rats exhibited less than a 10 % incidence.41 Drew et al. also reported that rats, mice, and
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hamsters exposed to 50-200 ppm VC by inhalation (6 h/day, 5 days/week) regardless of
duration of exposure, had a higher incidence of neoplasms when exposures are started early
in life.42 It was also shown that rat fetuses and neonates have higher susceptibility to
angiosarcomas, and hepatocellular carcinomas.44, 45
Animal studies also indicated that young animals are more susceptible than adults to the
formation of DNA adducts by VC exposures.46-48 It was previously reported that following
VC exposure via inhalation (600 ppm, 4 h/day, 5 days), 7-OEG and εG concentrations in 10
day old rats were ~ 4-fold higher than lactating rats.46 Age dependent differences in
formation of εG by VC exposure were also studied by Morinello et al.47 The concentration
of εG in hepatocytes from weanling rats exposed to 1100 ppm VC (6 h/day, 5 days/week, 1
week) was reported to be ~ 1.8-fold greater than that found in adult rats.47
Several methods were developed to measure 7-OEG induced by VC in mice and
rats.12,13,49,50 Fedtke et al. used HPLC to determine the formation and persistence of 7-OEG
in female rats exposed to 600 ppm VC.9,10,51 The half-life of 7-OEG in these animals was
reported as 62 h, which was shorter than found for the etheno adducts. The concentration of
7-OEG was also measured by LC-MS/MS after the reduction of 7-OEG to 7-(2-
hydroxyethyl)guanine (7-HEG) with NaCNBH3.47 In that study, 7-OEG was detectable in
hepatocytes, but not adjoining nonparenchymal cells.
In the present study, we developed a new highly sensitive and specific LC-MS/MS method
to analyze 7-OEG in tissues from both adult and weanling male rats exposed to 1100 ppm
[13C2]-VC for 5 days and 1100 ppm VC for 1 day. Because of the increased sensitivity of
the new assay and the use of stable isotope labeled VC, we were able to detect and quantify
endogenous 7-OEG in vivo in tissues of control rats, and [13C2]-VC exposed rats (Figure 1,
2). We hypothesized that the source leading to the formation of 7-OEG was lipid
peroxidation and present data to support our hypothesis. The reaction of calf thymus DNA
(CtDNA) with [13C18]-ethyl linoleate (EtLa) under peroxidizing conditions resulted in the
formation of [13C2]-7-OEG,52 which could be quantified by LC/MS-MS (Figure 3). In
addition to quantitating endogenous and exogenous 7-OEG after [13C2]-VC exposures, the
half-life of [13C2]-7-OEG in liver and lung was determined.
Materials and Methods
Chemicals
VC is a known carcinogen and should be handled carefully in an operating fume hood with
protective equipment (i.e., gloves and laboratory coat). [13C2]-VC (≥98% chemical purity;
99% isotopic purity) and [15N5]-dG (98% isotopic purity) were obtained from Cambridge
Isotope Laboratories (Andover, MA). HPLC grade water, methanol, and acetic acid were
purchased from Thermo Fisher Scientific (Raleigh, NC), ethylene oxide, O-t-butyl
hydroxylamine, RNase A, calf thymus DNA and dG were purchased from Sigma Aldrich
(St. Louis, MO), t-butyl hypochlorite was purchased from TCI America (Portland, OR).
Nucleic acid purification grade lysis buffer, protein precipitation solution and proteinase K
were purchased from Qiagen (Valencia, CA).
Synthesis of 7-OEG Analyte and Internal Standards
7-OEG was synthesized from the reaction of CEO with dG. CEO was synthesized as
previously described by Holt et al. 53 by photochlorination of ethylene oxide with t-butyl
hypochlorite. After distillation of the crude product, the exact composition of the collected
product was verified by 1H NMR. A solution of dG (20 mM) in water was reacted with
excess CEO in a sealed tube at room temperature for 15 min, then at 37 °C for an additional
15 min. After hydrolysis with 0.1 N HCl at 70 °C for 40 min, 7-OEG standard was purified
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by HPLC. Chromatography was performed on a RP-18 (15 × 3.2 mm) precolumn (Brownlee
Labs) attached to RP-SCX column (ES Industries, Chromega column, 250 × 4.6 mm, 5 μm)
with a flow rate of 1.5 mL/min using a linear gradient program from 20% B to 100% B in 20
min. (A: 75 mM ammonium formate / 10% acetonitrile (ACN), pH 2.8 and B: 250 mM
ammonium formate / 10% ACN, pH 2.8).49 7-OEG analyte standard (AST) was collected at
~7 min and quantified by fluorescence measurement with excitation wavelength of 255 nm
and a 340 nm emission cut-off filter. Isotopically labeled 7-OEG internal standard (IST) also
was synthesized from the reaction of [15N5]-dG with CEO as described and purified by the
same procedure as for analyte standard.
Animals, Exposure and Tissue Collection
Inhalation exposures were conducted at the USEPA NHEERL facility in Research Triangle
Park, NC. All procedures that involved the use of animals were approved by the USEPA
Institutional Animal Care and Use Committee. Ten week old (300-325 g) adult and 21 day
old (50-60 g) weanling male Sprague Dawley rats were purchased from Charles River
Laboratories (Raleigh, NC). The rats were acclimated for 1 week and housed in stainless
steel cages with a 12-h light/dark cycle. Four adult and eight weanling animals per group
were exposed to 1100 ppm VC in a nose only inhalation apparatus for 1 day [6 h/day, 1
day], or to 1100 ppm [13C2]-VC [6 h/day] for 5 days. The VC vapor was generated by
metering pure VC or [13C2]-VC vapor into a mixing chamber with medical grade air using
mass flow controllers (Tylan Instruments, Torrance CA). VC vapor was delivered to the
inlet of the nose-only chamber (CH Technologies, Westwood, NJ) after the concentration
was determined using a Miran 1A infrared gas analyzer (Foxboro, MA) which was
calibrated with vinyl chloride (Scott Gas, 99.96% purity). Temperature and relative
humidity were monitored during the exposures using an Omega Model RH411 Thermo-
Hygrograph (Stamford, CT), and were within the acceptable limits for nose-only exposures.
At the end of exposure, the rats were anesthetized with Euthasol® by intraperitonial
injection and euthanized by exsanguination via the vena cava. The liver, lung, kidney,
spleen, testis, and brain were removed, frozen on dry ice and stored at −80 °C. Following 5
days of [13C2]-VC exposure, 4 adults and all 8 weanling rats were euthanized within 2 h of
the completion of exposure. Three additional groups of 4 adults were euthanized 2, 4 or 8
weeks later to determine the half-life of [13C2]-VC DNA adducts.
DNA Isolation
DNA isolation from tissues was performed as previously described22 with minor
modifications using the Gentra Systems DNA extraction kit. The homogenized tissues were
incubated in lysis buffer with the addition of 20 mM 2,2,6,6-tetramethyl-1-piperidinyloxy
(TEMPO), followed by protein precipitation solution. After protein precipitation, the DNA/
RNA mixture was precipitated by isopropanol. The DNA/RNA pellet then was resuspended
in lysis buffer containing TEMPO and incubated with RNase A at 37 °C for 30 min, which
was then followed by protein and DNA precipitation. The DNA pellet was resuspended in
distilled water containing 1 mM TEMPO and stored at -80 °C until analysis. DNA was
quantified by a Biomate UV spectrophotometer (Thermo Scientific) at A260 and calculated
as 1AU = 50 μg/mL.
DNA Hydrolysis
DNA solutions (50 μg) were spiked with the IST (640 fmol, [15N5]-7-OEG) and diluted to
500 μL with HPLC water. Samples were incubated at 100 °C for 30 min. Immediately after
incubation samples were cooled on ice. The DNA backbone was separated by Microcon 10
filtration (11500 rpm, 4 °C, 40 min), after which the filtrate was placed in a separate tube
and 400 μL HPLC water was added to the retentate to wash the DNA backbone (11500 rpm,
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4 °C, 40 min), followed by combining both filtrates. Four mM O-t-butyl hydroxylamine (O-
tBHA) (50 μL) and methanol (100 μL) were added to each DNA filtrate and incubated at 45
°C for 30 min., dried by vacuum evaporation in a SpeedVac concentrator. The dried
fractions were transferred to glass autosampler vials by rehydration with HPLC water (3 ×
100 μL), dried under vacuum, and then diluted in 50 μL HPLC water to be analyzed by LC-
MS/MS. Positive CtDNA controls (with and without O-tBHA) and negative reagent-only
controls (with and without O-tBHA) were also prepared as described above. These samples
proved no artificial contribution to the exogenous mass transitions, and endogenous 7-OEG
was present only in samples containing DNA.
LC-MS/MS Analysis
Quantitative LC-MS/MS data were obtained using a Thermo Finnigan TSQ Quantum Ultra
triple-quadrupole mass spectrometer equipped with Waters Acquity UPLC. A heated
electrospray ionization (HESI) interface was operated in positive selected reaction
monitoring (SRM) mode. The transitions monitored were m/z 265 → 152 for 7-OEG-tBHA
(Figure 4), m/z 267 → 152 for 13C2-7-OEG-tBHA, and m/z 270 → 157 for [15N5]-7-OEG-
tBHA. The method gave a detection limit of 1 fmol on the column using an injection volume
of 5 μL. Samples were kept at 4°C in the autosampler during analysis. Separation was
performed on a Thermo Scientific Aquasil C18 column (150 × 1mm, 5 μ) with a flow rate of
0.120 mL/min using the following gradient (A) 0.1% acetic acid in water and (B)
acetonitrile; 0-1.5 min, 5% B; 1.5-3 min, 30 % B; 3-6 min, 90 % B; 6-7 min, 5 % B; 7-12
min, 5%B.
Instrument conditions were optimized for maximum signal of 7-OEG by direct infusion of
AST and IST. MS settings were as follows: electrospray voltage, 3000 V, capillary
temperature, 285 °C, HESI temperature, 150 °C, sheath and auxiliary gas pressures, 30 and
20 arbitrary units, collision energy, 20 V, and Q2 collision gas pressure, 1.5 mTorr.
Calibration curves using O-tBHA derivatized 7-OEG AST and [15N5]-7-OEG IST in HPLC
water were generated by diluting from derivatized stock standards with each sample set.
Standard curves were calculated using the peak area ratio of 7-OEG-tBHA to IST versus
fmol 7-OEG-tBHA injected (Figure 5). The amounts of both 7-OEG and exogenously
derived [13C2]-7-OEG in each sample were calculated from the ratio of the AST and IST
peak areas.
Injection of a high amount of [15N5]-7-OEG-tBHA IST (> 3 pmol) showed no contribution
to either the endogenous or exogenous mass transitions.
Assay performance was evaluated by adding known amounts of 7-OEG to freshly isolated
CtDNA. DNA was quantified by UV before spiking 50 μg aliquots with 3.2, 32, and 64 fmol
7-OEG and 640 fmol IST. Sample sets were assayed on two different days by separate
analysts and results are summarized in Table 1. The endogenous 7-OEG concentration found
in CtDNA was determined to be 2.4 ± 0.8 fmol (n=5) per 50 μg DNA.
Reaction of [13C18]-Ethyl Linoleate with CtDNA
The reaction of [13C18]-EtLa with CtDNA was carried out according to a previously
published method29 with minor modifications. Ten mg of [13C18]-EtLa (100 μL, 100 mG /
mL in methanol) was added to 300 μg CtDNA in 1 mL of 50 mM sodium phosphate buffer
(pH 7.4). After addition of 10 μL of t-butylhydroperoxide (70 % solution, 70 μmol), the
mixture was incubated at 37 °C for 24 hrs. After the addition of 1 mL water, 10 μL of 2 %
butylated hydroxytoluene in isopropanol (w/v) and 0.5 mL of methanol to the reaction
mixture, the sample was extracted 2 times with 2 mL of chloroform containing 0.5% t-
butylhydroperoxide (w/v); the aqueous layer was dried under vacuum and the sample was
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resuspended in 1 mL of water. Samples were left at 4 °C overnight to rehydrate and stored at
− 80 °C until analysis.
Results and Discussion
Although 7-OEG lacks miscoding properties, it is the major DNA adduct formed by VC and
is therefore an important biomarker for VC exposure. This paper details a new approach to
determine the formation and persistence of 7-OEG. We developed a sensitive LC/MS-MS
analysis to determine 7-OEG concentrations in tissue DNA of male Sprague Dawley rats
exposed to 1100 ppm VC for 1 day, or [13C2]-VC for 5 days, including post exposure
periods of 2, 4 or 8 weeks. The new 7-OEG assay utilized an oximation reaction with O-
tBHA, which allowed us to measure 7-OEG as a more stable oxime adduct. Using this new
highly sensitive assay we determined that 7-OEG concentrations were ~200-fold higher than
εG in liver of adult rats similarly exposed to VC.48 Laib et al. reported similar results for
adduct formation in liver of rats exposed to VC (1:100 ratio).12
The exposure of adult and weanling rats to 1100 ppm [13C2]-VC for 1 week induced
[13C2]-7-OEG in liver, lung, kidney, spleen, brain and testis as summarized in Table 2.
Stable isotope-labeled VC exposures allowed us to distinguish 7-OEG from [13C2]-7-OEG
and demonstrated that 7-OEG is formed endogenously. This is clearly shown in Figures 1
and 2 which contrast chromatograms from an unexposed control animal to one subjected to
5 day [13C2]-VC exposure. The greatest concentration of [13C2]-7-OEG detected in DNA
from adult rats exposed to 1100 ppm [13C2]-VC for 5 days was found in liver, with 104.0 ±
23.0 adducts per 106 guanine. Lung, kidney and spleen had the next highest concentrations
of [13C2]-7-OEG with 39.0 ± 2.0, 28.0 ± 7.0, and 10.0 ± 2.0 adducts per 106 guanine,
respectively. Brain (3.0 ± 0.3) and testis (1.0 ± 0.1) had the lowest number of [13C2]-7-OEG
adducts per 106 guanine.
We found that the concentrations of exogenous 7-OEG adducts were ~50-fold higher than
endogenous 7-OEG in adult livers and ~300-fold higher in weanling rat livers. The
endogenous 7-OEG adduct concentrations in target tissues in adult and weanling rats
showed no significant difference. Therefore we conclude that there is no effect of age on the
endogenous 7-OEG formation. The ratio of exogenous/endogenous 7-OEG in adult rats was
~200-fold in lung, ~40-fold in kidney, ~4-fold in brain, and ~1.7-fold higher in spleen, while
in testis it was ~0.1-fold.
The formation of [13C2]-7-OEG in liver of weanling rats was ~3-fold greater than adult rats,
with 299.0 ± 129.0 adducts per 106 guanine. This is thought to be due to age related
differences in metabolism due to greater CYP2E1 activity in weanling rats. A recent study
has shown up to 2-fold higher CYP2E1 activity in 3 week old rat liver.54 In comparison to
the adult rats, weanling rats had [13C2]-7-OEG concentrations in lung, kidney and spleen
that were approximately 2-fold higher than adults (Table 2 and 3). Three-fold higher
[13C2]-7-OEG was also detected in brains of weanling rats exposed to 1100 ppm [13C2]-VC
for 5 days, compared to the exogenous concentrations found in similarly exposed adult rats,
but was still 30 times lower than weanling liver. The lowest exogenous 7-OEG was detected
in spleen for both weanling and adult rats, which might suggest that P450 metabolism of VC
in this tissue is minimal. In contrast, endogenous 7-OEG formation was highest in spleen
and testis for both adult and weanling rats compared to other tissues.
Persistence of 7-OEG was also determined in adults rats euthanized 2, 4 and 8 weeks after
exposure to [13C2]-VC for 5 days (Table 2). The half-life of [13C2]-7-OEG was calculated in
liver and lung DNA by using the plot of log (adducts) versus days (Figure 6). The half-life
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of [13C2]-7-OEG in liver and lung was ~4 days, which is consistent with other studies on
N7-guanine adducts. This is thought to primarily represent chemical depurination.
Previously 7-OEG formation was determined by Fedtke et al. in rats exposed to 600 ppm
VC (1wk).10 DNA (1-2 mg) was depurinated by acid hydrolysis and analyzed by HPLC
using fluorescence detection with a limit of detection 10 pmol 7-OEG per μmol guanine. 7-
OEG was shown to be 144 times higher than εG. While the data obtained from these studies
gave important information on DNA adduct formation from VC exposures, it lacked the
sensitivity of the present LC-MS/MS assay. Using our mass spectrometry method, we were
able to quantify DNA adducts by using a stable isotope-labeled 7-OEG IST, while in the
previous HPLC method, adducts were quantified by external calibration using CtDNA
spiked with 7-OEG. In the previous studies, neither endogenous 7-OEG in control samples,
nor exogenous 7-OEG in brain and spleen of exposed weanling rats could be detected. In
comparison, the adduct ratio of 7-OEG was 1:1 in lung of adult and weanling rats, whereas
in liver it was 4 fold higher in weanlings. The half-life of 7-OEG was also calculated as 63
hrs, while in the present study, it was ~96 hrs.10
Morinello et al. also examined 7-OEG concentrations in hepatocyte and brain DNA of rats
exposed to 1100 ppm VC for 1 week (6 h/day, 5 days/week) and demonstrated that 7-OEG
was only detectable in hepatocyte DNA at 4 ± 0.9 adducts per 106 guanine. 47 7-OEG was
measured as 7-HEG after NaCNBH3 reduction and analyzed by LC-MS/MS with a limit of
detection 0.3 adducts per 106 guanine. Since only DNA of unlabeled VC exposed rats was
analyzed, no distinction was made between endogenous and exogenous 7-OEG formation.
7-OEG concentrations reported by Morinello et al.47 were ~25-fold lower than exogenous 7-
OEG concentrations we report in this study (Table 2). Because the sufficiency of NaCNBH3
reduction of 7-OEG is not known, we suggest that incompletion of the reduction of 7-OEG
in DNA might be an important factor for the lower 7-OEG concentration found in that study.
For comparison reasons we also analyzed lung, kidney and brain DNA of rats exposed to
[13C2]-VC from Morinello et al. study.47 Endogenous and exogenous 7-OEG concentrations
in those samples were very similar to the concentrations reported in this study (Table 4).
The data obtained from CtDNA, control and [13C2]-VC-exposed animals demonstrated that
7-OEG is formed endogenously in relatively high concentrations in comparison to other
endogenous N7-guanine adducts. While endogenous concentrations of 7-HEG in tissues
from control rats and mice were reported to range from 1 to 4 adducts per 108
nucleotides,55,56 endogenous N7-methylguanine ranged from 2 to 2.5 adducts per 107
nucleotides.57
Based on previous data showing the formation of etheno DNA adducts by lipid
peroxidation, we hypothesized that endogenous 7-OEG was also formed as a result of lipid
peroxidation.52 Previously, the key LPO intermediates that have been identified for the
formation of DNA adducts19,58-60 are the result of reactions of HNE, ONE and MDA with
dG and are associated with DNA adducts formed by VC exposure.58
Previously, the lack of evidence for endogenous 7-OEG formation did not suggest a
rationale for studying its formation in vitro and/or in vivo. The detection of endogenous 7-
OEG in the present study (Figure 1 and 2) prompted us to examine its route of formation.
We tested the reaction of CtDNA with [13C18]-EtLa under peroxidizing conditions.52 The
formation of 7-OEG by direct alkylation was evaluated by monitoring the incorporation of
the 13C-labeled stable isotope from EtLa into 7-OEG (Figure 3). Previously Chung et al.61
and Ham et al.52 had demonstrated the formation of etheno adducts 1,N2-ethenoguanine,
1,N6-ethenodeoxyadenine, and N2,3-ethenoguanine as a result of the reaction between dG
with HNE, calf thymus DNA with HNE and EtLa under peroxidation conditions.
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7-OEG formation in adult and weanling rats exposed to 1100 ppm VC for 1 day was also
determined (Table 5). In adult and weanling rats exposed to unlabeled VC, the concentration
of 7-OEG adduct was 64.0 ± 49.0 and 84.0 ± 47.0 in liver, 28.0 ± 6.0 and 37.0 ± 11.0 in
lung, 19.0 ± 3.0 and 28.0 ± 12.0 in kidney, 1.6 ± 0.5 and 1.5 ± 0.6 adducts per 106 guanine
in brain, respectively. These animals were exposed to VC to test the nose-only inhalation
apparatus before starting [13C2]-VC exposures, but provided additional information about
the effect of age, tissue and duration of exposure on 7-OEG formation. The age-dependent
formation of 7-OEG in liver from weanling rats exposed to 1100 ppm VC (1 day) was ~1.3-
fold greater than the concentrations in liver of adult rats exposed to 1100 ppm VC (1 day).
The concentration of 7-OEG in lung, kidney, and brain from weanling rats was similar to
adult rats exposed for the same duration. While 7-OEG adducts in liver, lung, and kidney
were higher than control animals for both adult and weanling rats, in brain it was similar to
that of control animals. These data, however, reflect a mixture of endogenous and
exogenous adducts, as no distinction between the two could be made.
In this study, we determined the concentration of 7-OEG in liver, lung, kidney, spleen, testis
and brain DNA from animals exposed to VC and [13C2]-VC and demonstrated the presence
of endogenous 7-OEG in brain, liver, lung, kidney, spleen and testis. Persistence of 7-OEG
in liver, lung, kidney, and spleen was also demonstrated in this study. The molecular
dosimetry data suggest that not only liver, but also other organs such as lung and kidney
might be considered target organs for VC-induced carcinogenesis following inhalation
exposure. Due to the reactivity and short half-life of CEO, 1.6 min in aqueous solution at
natural pH,62 we hypothesize that VC is metabolized in each organ by P450, rather than
arising via the circulation of CEO in the body. The lower exogenous adduct level in brain,
spleen and testis supports this.
The data described in this study and its companion studies will help to understand the
relative formation of endogenous and exogenous DNA adducts of VC. The identification of
7-OEG and the etheno DNA adducts as endogenous DNA lesions has important implications
for risk assessment since background amounts will always be present. The new data support
the carcinogenesis and epidemiology findings that VC is causally associated with cancer
following relatively high exposures. In contrast, the number of endogenous adducts is
greater than identical exogenous adducts formed at low exposures.
In summary, we developed a new sensitive, selective and efficient LC-MS/MS method for
quantification of 7-OEG in DNA. For the first time, endogenous 7-OEG was detected in
control rats and [13C2]-VC exposed rats and its endogenous formation from lipid
peroxidation was confirmed in vitro in CtDNA. The half-life of 7-OEG in liver and lung was
determined to be ~ 4 days.
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Chromatograms of (A) brain DNA from an adult rat exposed to 1100 ppm [13C2]-VC for 5
days, 6h per day and (B) brain DNA from an unexposed adult rat.
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Chromatograms of (A) liver DNA from an adult rat exposed to 1100 ppm [13C2]-VC for 5
days, 6h per day and (B) liver DNA from an unexposed adult rat.
Mutlu et al. Page 14














Chromatograms of (A) CtDNA reacted with [13C18]-EtLa for 89 hr, and (B) control CtDNA.
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Product ion spectrum of 7-OEG-tBHA (precursor ion m/z 265). The spectrum was obtained
by injecting 6.4 pmol of 7-OEG-tBHA on the LC system, selecting m/z 265 in Q1 and
scanning Q3 from m/z 50 to 300. Argon collision gas pressure was 1.5 mTorr, and collision
energy was 20 eV.
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Calibration curve for 7-OEG-tBHA obtained under SRM conditions using the present LC-
MS/MS method. The plot shows the peak area ratio of 7-OEG-tBHA to internal standard
versus increasing fmol of 7-OEG-tBHA. Data points corresponds to standard mixtures that
give 1.6, 3.2, 6.4, 16, 32, 64, 160, 320, and 640 fmol 7-OEG-tBHA and 640 fmol [15N5]-7-
OEG-tBHA on column.
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Plot of log (7-OEG/ 108 gua) versus days was used to determine the half-life of 7-OEG in
the liver and lung of adult rats exposed to [13C2]-VC (1100 ppm, 5 days, 6h per day) and
euthanized at the end of exposure, or 2, 4, 8 weeks later. The half-life of 7-OEG in liver and
lung is 4 days on the basis of the equations.
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Vinyl chloride induced major DNA adduct, 7-OEG. In the case of [13C2]-VC exposures, *
indicates positions of labeled atoms.
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Table 1





found day 1 (n=5)
fmol 7-OEG
found day 2 (n=5)
Combined interday
results (n=10)
3.2 7.9 ± 3.3 7.4 ± 3.3 7.6 ± 3.1
32 34.8 ± 7.3 38.3 ± 7.7 36.6 ± 7.1
64 70.4 ± 10.3 69.0 ± 9.2 70.0 ± 9.2
a
Data are presented as the mean fmol found per sample ± standard deviation. Amounts measured in this standard deviation are the combination of
the endogenous concentration and spiked concentration 7-OEG.














































































































































































































































































































































































































































































Mutlu et al. Page 22
Table 3
7-OEG (endogenous) and [13C2]-7-OEG (exogenous) adduct concentrations determined from weanling (n=8)
rats exposed to 1100 ppm [13C2]-VC for 5 days and cage controls.
Weanling Control
Weanling 2 hrs post
exposure
7-OEG 13C2-7-OEG 7-OEG 13C2-7-OEG
Liver
(add/ 106 gua) 0.8±0.1 — 1.0±0.5 299.0±129.0
Lung
(add/ 106 gua) 0.5±0.1 — 0.4±0.1 83.0±19.0
Kidney
(add/ 106 gua) 2.7±1.0 — 0.8±0.3 66.0±12.0
Brain
(add/ 106 gua) 5.0±2.0 — 1.0±0.3 10.0±0.8
Spleen
(add/ 106 gua) 3.8±1.1 — 7.0±5.0 16.0±2.0
Testis
(add/ 106 gua) 1.0±0.6 — 6.0±0.2 1.2±0.1
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Table 4
7-OEG (endogenous) and [13C2]-7-OEG (exogenous) adduct concentrations determined from adult rats
exposed to 1100 ppm [13C2]-VC for 5 days. Tissues were analyzed from Morinello et al.47.
Adult
Control
Adult 2 hrs post
exposure
7-OEG 13C2-7-OEG 7-OEG 13C2-7-OEG
Lung (n=8)
(add/ 106 gua) NA — 0.6±0.2 31.0±11.0
Kidney (n=7)
(add/ 106 gua) NA — 0.8±0.4 22.0±3.0
Brain (n=3, 1)*
(add/ 106 gua) 5.0±1.0 — 1.0 2.0
*
Brain control, n=3; Brain exposed, n=1.
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Table 5
7-OEG (endogenous + exogenous) adduct concentrations determined from weanling (n=8) and adult (n=4) rats









7-OEG 7-OEG 7-OEG 7-OEG
Weanling
1 d exposure 84.0 ± 47.0 37.0 ± 11.0 28.0 ± 12.0 1.5 ± 0.6
Adult
1 d exposure 64.0 ± 49.0 28.0 ± 6.0 19.0 ± 3.0 1.6 ± 0.5
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